Literature DB >> 17108101

Markers and tissue resources for melanoma: meeting report.

Dorothea Becker1, Martin C Mihm, Stephen M Hewitt, Vernon K Sondak, Jane W Fountain, Magdalena Thurin.   

Abstract

The Markers and Tissue Resources for Melanoma meeting convened by the Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, Specialized Programs of Research Excellence at the Organ Systems Branch of the National Cancer Institute (NCI), and the Melanoma Research Foundation was held in Gaithersburg, MD on October 2005. The meeting reviewed the current status of biomarkers for early- and advanced-stage melanoma and addressed some of the challenges scientists and clinicians face as they unravel the biology of melanoma and try to apply these findings to patient care. Specifically, the participants focused on molecular changes associated with melanoma progression, potential diagnostic and prognostic markers emerging from molecular profiling studies, and new treatment targets for current and future clinical trials. They also highlighted the ongoing challenges about translational research in melanoma, including availability of tissue resources, and summarized the status of nevus and melanoma tissue microarrays, recently developed as a collaborative project between the melanoma research community and the NCI. The meeting report is intended to provide a perspective on emerging scientific approaches in translational research that can enhance the progress in discovery and validation of markers for melanoma. (Cancer Res 2006; 66(22): 10652-7).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17108101     DOI: 10.1158/0008-5472.CAN-06-0921

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Quantitative measurement of circulating lymphoid-specific helicase (HELLS) gene transcript: a potential serum biomarker for melanoma metastasis.

Authors:  Hye-Eun Kim; James T Symanowski; Erika E Samlowski; Jason Gonzales; Byungwoo Ryu
Journal:  Pigment Cell Melanoma Res       Date:  2010-08-18       Impact factor: 4.693

2.  Biomarkers of cancer metastasis through the lymphovascular system: future perspectives.

Authors:  Stanley P L Leong; Marlys Witte
Journal:  Clin Exp Metastasis       Date:  2012-08-15       Impact factor: 5.150

Review 3.  Progression of cutaneous melanoma: implications for treatment.

Authors:  Stanley P L Leong; Martin C Mihm; George F Murphy; Dave S B Hoon; Mohammed Kashani-Sabet; Sanjiv S Agarwala; Jonathan S Zager; Axel Hauschild; Vernon K Sondak; Valerie Guild; John M Kirkwood
Journal:  Clin Exp Metastasis       Date:  2012-08-15       Impact factor: 5.150

4.  Tissue resources for clinical use and marker studies in melanoma.

Authors:  Jonathan L Curry; Michael A Davies; Tiffany L Calderone; Katherine Nathanson; Victor G Prieto; Jeffrey E Gershenwald
Journal:  Methods Mol Biol       Date:  2014

5.  A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum.

Authors:  Caterina Longo; Guido Gambara; Virginia Espina; Alessandra Luchini; Barney Bishop; Alexis S Patanarut; Emanuel F Petricoin; Francesca Beretti; Barbara Ferrari; Enrico Garaci; Anto De Pol; Giovanni Pellacani; Lance A Liotta
Journal:  Exp Dermatol       Date:  2011-01       Impact factor: 3.960

6.  Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research.

Authors:  Lindsay G Wich; Heather K Hamilton; Richard L Shapiro; Anna Pavlick; Russell S Berman; David Polsky; Judith D Goldberg; Eva Hernando; Prashiela Manga; Michelle Krogsgaard; Hideko Kamino; Farbod Darvishian; Peng Lee; Seth J Orlow; Harry Ostrer; Nina Bhardwaj; Iman Osman
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

7.  Increased shedding of HU177 correlates with worse prognosis in primary melanoma.

Authors:  Heather K Hamilton; Amy E Rose; Paul J Christos; Richard L Shapiro; Russell S Berman; Madhu Mazumdar; Michelle W Ma; Daniel Krich; Leonard Liebes; Peter C Brooks; Iman Osman
Journal:  J Transl Med       Date:  2010-02-23       Impact factor: 5.531

Review 8.  Tissue microarrays as a tool in the discovery and validation of tumor markers.

Authors:  Stephen M Hewitt
Journal:  Methods Mol Biol       Date:  2009

9.  Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells.

Authors:  Andrzej Slominski; Blazej Zbytek; Radomir Slominski
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

10.  Increased serum level of thymidine kinase 1 correlates with metastatic site in patients with malignant melanoma.

Authors:  Bao-Jin Wu; Wen-Peng Li; Cheng Qian; Wei Ding; Zhong-Wen Zhou; Hua Jiang
Journal:  Tumour Biol       Date:  2012-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.